Agneta K. Hurst
- Cardiology and Cardiovascular Medicine
- Pharmacology top 10%
- Pediatrics, Perinatology and Child Health
- Obstetrics and Gynecology top 10%
- Epidemiology
- Co-authors
- Avraham ShotanUri ElkayamJosef WiderhornRoger W. JelliffeEarl C. HarrisonTeresa IglesiasJulián Rodrı́guezRobert T. Koda
- Topics
- Antibiotics Pharmacokinetics and Efficacy (3 papers)Analytical Methods in Pharmaceuticals (3 papers)Heart Failure Treatment and Management (2 papers)
- Journals
- Journal of the American College of CardiologyThe American Journal of MedicineAntimicrobial Agents and Chemotherapy
- Partner nations
- United States
In The Last Decade
Agneta K. Hurst
13 papers receiving 354 citations
Peers
Comparison fields: 5 of 71
- Cardiology and Cardiovascular Medicine 124
- Pharmacology 116
- Pediatrics, Perinatology and Child Health 87
- Obstetrics and Gynecology 75
- Epidemiology 56
Countries citing papers authored by Agneta K. Hurst
This map shows the geographic impact of Agneta K. Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta K. Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta K. Hurst more than expected).
Fields of papers citing papers by Agneta K. Hurst
This network shows the impact of papers produced by Agneta K. Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta K. Hurst. The network helps show where Agneta K. Hurst may publish in the future.
Co-authorship network of co-authors of Agneta K. Hurst
This figure shows the co-authorship network connecting the top 25 collaborators of Agneta K. Hurst. A scholar is included among the top collaborators of Agneta K. Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta K. Hurst. Agneta K. Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 184 | |
| 5 | 11 | |
| 6 | 48 | |
| 7 | 73 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis. | 9 |
| 11 | Blood-sampling strategy for monitoring continuous intravenous heparin therapy. | 2 |
| 12 | 7 | |
| 13 | Metaproterenol, a potent and safe bronchodilator. | 20 |
About Agneta K. Hurst
Agneta K. Hurst is a scholar working on Analytical Chemistry, Internal Medicine and Geriatrics and Gerontology, having authored 13 papers that have together received 385 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Heart Failure Treatment and Management (2 papers). The work is most often cited by research in Obstetrics and Gynecology (75 citations), Pharmacology (116 citations) and Cardiology and Cardiovascular Medicine (124 citations). Agneta K. Hurst has collaborated with scholars based in United States. Frequent co-authors include Avraham Shotan, Uri Elkayam, Josef Widerhorn, Roger W. Jelliffe, Earl C. Harrison, Teresa Iglesias, Julián Rodrı́guez, Robert T. Koda, Ken Iseri and T. Murphy Goodwin. Their work appears in journals such as Journal of the American College of Cardiology, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.